# The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 1)

> **NCT07303738** · PHASE4 · RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Feeding Difficulties
- Aspiration
- Gastrostomy

## Interventions

- **DRUG:** amino acid based formula (e.g. Elecare Jr)
- **DRUG:** low bile acid binding blenderized diet (e.g. Kate Farms)
- **DRUG:** high bile acid binding blenderized diet

## Key facts

- **NCT ID:** NCT07303738
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2030-08
- **Final completion:** 2030-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07303738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07303738, "The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 1)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07303738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*